Validation of Dynamic Deuterium Metabolic Imaging (DMI) for the Measurement of Cerebral Metabolic Rates of Glucose in Rat
NMR in Biomedicine · 2026
DOI: 10.1002/nbm.70194 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift NMR in Biomedicine, 2026. Verfasst von Claudius S Mathy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Biomedical Imaging, Magnetic Resonance Research Center, Yale University, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Glucose, Deuterium, Brain, Magnetic Resonance Imaging. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Deutsche Forschungsgemeinschaft, US National Institutes of Health.
Abstract (Originalsprache)
Deuterium metabolic imaging (DMI) is an innovative technique in which 2 H magnetic resonance spectroscopic imaging (MRSI) is utilized to determine the metabolic activity of administered 2 H‐labeled substrates. As such it can be viewed as the 2 H counterpart to more traditional 13 C labeling methods that can be considered the gold standard for metabolic mapping in vivo. To ensure reliable findings from dynamic 2 H MRSI experiments about absolute metabolic flux rates after administration of a 2 H‐labeled substrate it is essential to take into account 2 H‐specific aspects, namely 2 H label losses and kinetic isotopy effects (KIEs). Here, a modified version of a 13 C‐based metabolic model for glucose metabolism in rat brain was developed to address these 2 H‐related effects, tested for 2 H MRSI data acquired during infusion of [6,6'‐ 2 H 2 ]‐glucose, and validated by comparison with indirect 1 H‐[ 13 C] MRSI data acquired during infusion of [1‐ 13 C]‐glucose. The flux rates for glucose consumption (CMR gl = 0.57 ± 0.08 μmol/min/g) and the TCA cycle (V tca = 1.24 ± 0.14 μmol/min/g) derived from the 2 H MRSI data and using the updated metabolic model were in excellent agreement with the estimates based on 13 C data (CMR gl = 0.59 ± 0.14 μmol/min/g and V tca = 1.24 ± 0.32 μmol/min/g). The successful validation of dynamic 2 H MRSI for absolute flux rate determination forms the basis for future quantitative study of metabolic disorders in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Biomedical Imaging, Magnetic Resonance Research Center, Yale University, New Haven, Connecticut, USA.
- Institute of Physical and Theoretical Chemistry, University of Bonn, Bonn, Germany.
- Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
- Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA.
ORCID-Profile: Henk M De Feyter
Förderung
- NCI NIH HHS
- Deutsche Forschungsgemeinschaft
- US National Institutes of Health
- NIBIB NIH HHS
- National Institutes of Health
Zitieren
APA
Mathy, C. S., Thomas, M. A., Mason, G. F., de Graaf, R. A., & De Feyter, H. M. (2026). Validation of Dynamic Deuterium Metabolic Imaging (DMI) for the Measurement of Cerebral Metabolic Rates of Glucose in Rat. NMR in Biomedicine. https://doi.org/10.1002/nbm.70194
Vancouver
Mathy CS, Thomas MA, Mason GF, de Graaf RA, De Feyter HM. Validation of Dynamic Deuterium Metabolic Imaging (DMI) for the Measurement of Cerebral Metabolic Rates of Glucose in Rat. NMR in Biomedicine. 2026. doi:10.1002/nbm.70194
BibTeX
@article{Mathy2026,
author = {Mathy, Claudius S and Thomas, Monique A and Mason, Graeme F and de Graaf, Robin A and De Feyter, Henk M},
title = {Validation of Dynamic Deuterium Metabolic Imaging (DMI) for the Measurement of Cerebral Metabolic Rates of Glucose in Rat},
journal = {NMR in Biomedicine},
year = {2026},
doi = {10.1002/nbm.70194}
}
EUVIMED